EUVIMEDEUVIMED entdecken
Crossref

RHD ‐negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen

David Juhl iD, Kathrin Luckner, Christian Brockmann, Ingrid Musiolik, Tina Bunge-Philipowski, Siegfried Görg, Malte Ziemann iD

Transfusion · 2024

DOI: 10.1111/trf.17691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von David Juhl und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Lübeck/Kiel, Germany. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Blood Group Antigens. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Serologic typing with monoclonal anti‐D is mandatory for RHD antigen determination before transfusion, but due to aberrant (weak or partial) variants of RHD, results may be ambiguous and molecular RHD‐typing is required. Before that, RHD‐negative (RHD –) red blood cells concentrates (RBCs) shall be transfused to avoid anti‐D formation, which probably leads to wastage of RHD ‐ RBCs. Study Design and Methods All patients with ambiguous results in serologic RHD‐typing and molecular RHD‐typing were assessed retrospectively. The proportions of patients at risk for anti‐D formation and the proportion of RHD ‐ RBCs transfused unnecessarily were evaluated for the following transfusion strategies: (1) RHD‐positive (RHD + )RBCs for all patients, (2) RHD + RBCs for patients with at least 2+ reaction with anti‐D, (3) RHD + RBCs for patients with C and/or E in their RHCE‐phenotype, (4) RHD + RBCs for patients with C and/or E and at least 2+ reaction, and (5) RHD ‐ RBCs for all patients.

Results

A total of 112 patients were included. Most had weak D type 1–3 and a minority had other, rare RHD variants. The risk of anti‐D formation was 4.5%, 2.9%, 1.8%, 1.0%, and 0% for strategies 1–5, respectively. The proportion of RHD ‐ RBCs transfused unnecessarily was 0%, 49.5%, 0.9%, 50.5%, and 95.5%.

Conclusion

Transfusing patients with a C and/or E in their RHCE‐phenotype with RHD + RBCs resulted in a very low risk of immunization while avoiding wastage of RHD ‐ RBCs. Therefore, this strategy should be used for some patients with ambiguous results in serologic RHD‐typing and pending results of molecular RHD‐typing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rh-Hr Blood-Group SystemBlood Group AntigensHumansRetrospective StudiesBlood TransfusionPhenotypeErythrocytesAllelesGenotype

Stichwörter der Autor:innen

RBC transfusionblood group genomicsimmunohematology (RBC serology, blood groups)

Substanzen

Rh-Hr Blood-Group SystemBlood Group Antigens

Autor:innen und Institutionen

  • Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Lübeck/Kiel, Germany.

ORCID-Profile: David Juhl, Malte Ziemann

Zitieren

APA

Juhl, D., Luckner, K., Brockmann, C., Musiolik, I., Bunge-Philipowski, T., Görg, S., & Ziemann, M. (2024). RHD ‐negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen. Transfusion. https://doi.org/10.1111/trf.17691

Vancouver

Juhl D, Luckner K, Brockmann C, Musiolik I, Bunge-Philipowski T, Görg S, et al. RHD ‐negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen. Transfusion. 2024. doi:10.1111/trf.17691

BibTeX
@article{Juhl2024,
  author = {Juhl, David and Luckner, Kathrin and Brockmann, Christian and Musiolik, Ingrid and Bunge-Philipowski, Tina and Görg, Siegfried and Ziemann, Malte},
  title = {RHD ‐negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17691}
}
Kostenlos starten →